Caplin Point Laboratories Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹2671.5Market Cap
₹ 19,871 Cr.Stock P/E
31.0ROE
20.6 %RSI
63.13Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]
Caplin Point Laboratories Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Caplin Point Laboratories Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Caplin Point Laboratories Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 2671.5 |
| RSI (14) | 63.13 |
| 50 DMA | 2278.77 |
| 200 DMA | 1943.44 |
| Trend | Bullish |
| A/D Rating | A+ |
| RS Rating | 94 |
| EPS Rating | 62 |
| TI65 | 1.21 |
| TI65 Trend | Bullish |
Pivot Points Analysis
Daily pivot points for Caplin Point Laboratories Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹2794.24 |
| R2 | ₹2739.37 |
| R1 | ₹2705.44 |
| PP | ₹2650.57 |
| S1 | ₹2616.64 |
| S2 | ₹2561.77 |
| S3 | ₹2527.84 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 19,871 Cr. |
| Current Price | ₹ 2,614 |
| High / Low | ₹ 2,700 / 1,500 |
| Stock P/E | 31.0 |
| Book Value | ₹ 472 |
| Dividend Yield | 0.23 % |
| ROCE | 24.6 % |
| ROE | 20.6 % |
| Face Value | ₹ 2.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 389 | 101 | 32% |
| Jun 2023 | 395 | 104 | 32% |
| Sep 2023 | 410 | 116 | 34% |
| Dec 2023 | 436 | 120 | 33% |
| Mar 2024 | 453 | 121 | 32% |
| Jun 2024 | 459 | 125 | 33% |
| Sep 2024 | 483 | 131 | 34% |
| Dec 2024 | 493 | 140 | 33% |
| Mar 2025 | 502 | 145 | 33% |
| Jun 2025 | 510 | 151 | 35% |
| Sep 2025 | 534 | 160 | 35% |
| Dec 2025 | 543 | 166 | 35% |
| Mar 2026 | 600 | 173 | 34% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 69.06% |
| FIIs | 5.19% |
| DIIs | 0.46% |
| Public | 25.29% |
| No. of Shareholders | 21,481 |
Pros and Cons
Pros
- Healthy return on equity of 20.6% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (2278.77).
- Outperforming over 70% of the entire market universe over the past 12 months.
Cons
Related NSE Stocks
Bajaj Finance Limited
View Share Price Analysis →Supreme Petrochem Limited
View Share Price Analysis →Aditya Birla Lifestyle Brands Limited
View Share Price Analysis →Berger Paints (I) Limited
View Share Price Analysis →Godrej Industries Limited
View Share Price Analysis →Vardhman Textiles Limited
View Share Price Analysis →Aster DM Healthcare Limited
View Share Price Analysis →Siemens Limited
View Share Price Analysis →K.P.R. Mill Limited
View Share Price Analysis →Mazagon Dock Shipbuilders Limited
View Share Price Analysis →Mangalore Refinery and Petrochemicals Limited
View Share Price Analysis →Anand Rathi Wealth Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Caplin Point Laboratories Ltd share?
Based on the latest closing data, the technical momentum for Caplin Point Laboratories Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 63.13, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (2278.77) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Caplin Point Laboratories Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Caplin Point Laboratories Ltd today centers at a Pivot Point (PP) of ₹2650.57. Upside resistance challenges are calculated at R1: ₹2705.44, R2: ₹2739.37, and R3: ₹2794.24. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹2616.64, S2: ₹2561.77, and S3: ₹2527.84.
How does the fundamental ROE and P/E ratio look for Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd is currently trading with a valuation metrics context of a Stock P/E of 31.0, against a core structural efficiency Return on Equity (ROE) standing at 20.6 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 62, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Caplin Point Laboratories Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Caplin Point Laboratories Ltd is tr... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A+, a Relative Strength (RS) ranking of 94, and long-term trend backing from the TI65 indicator (Bullish pattern).